Back

The responses of B-type natriuretic peptide (BNP), mature BNP, proBNP, atrial natriuretic peptide, and N-terminal proBNP to sacubitril/valsartan differs between responders and non-responders

30 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Diagnosis of heart failure: natriuretic peptides and novel methods Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Toshio Nishikimi

Wakakusa-Tatsuma Rehabilitation Hospital, Osaka (Japan)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor A. Tezuka (Tokyo, JP)
Abstract
Presentation thumbnail
Ms P. Rodriguez Montes (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Doctor M. Mckittrick (Limerick, IE)
Abstract Slides Video
Presentation thumbnail
Doctor C. Neerapattanakul (Bangkok, TH)
Abstract Slides

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Diagnosis of heart failure: natriuretic peptides and novel methods

The Event

Event poster

ESC Congress 2025

30 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Early increase and subsequent decrease in mature BNP and early decrease and continued decrease in proBNP after sacubitril/valsartan may relate to left ventricular reverse remodeling in heart failure
thumbnail
Congress Presentation
Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation
thumbnail
Congress Presentation
Comparison of NT-ProBNP levels in different groups of chronic heart failure: preliminary data analysis of research

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources